Healthcare -
Biotechnology - NASDAQ - US
$ 13.08
0.615 %
$ 1.12 B
Market Cap
-3.59
P/E
SNDX - STOCK-BASED COMPENSATION
Stock-based Compensation SNDX - Syndax Pharmaceuticals, Inc.
31 M
LAST VALUE
52.45%
2 YEAR CAGR
37.92%
5 YEAR CAGR
36.14%
10 YEAR CAGR